France’s biotech ecosystem: science, capital and scale

In this episode of Denatured, as part of our series on the European life sciences investment ecosystem, you'll be hearing from Ksenija Pavletic, partner and chief commercial officer at Jeito Capital and Thierry Laugel, managing partner at Kurma Partners. We dive into France’s biotech ecosystem and what still needs to happen for more early innovation to translate into investable, scalable biotech.

Host

⁠Jennifer C. Smith-Parker, Director of Insights, BioSpace

Guests

Ksenija Pavletic, Partner and Chief Commercial Officer, Jeito Capital

Thierry Laugel, Managing Partner, Kurma Partners

Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.